Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
Despite extensive evidence of fetal and neonatal risk, a large number of pregnant women are involved in excessive alcohol and drug abuse, such as with cocaine, methamphetamine, opioids, and cannabinoids.
Koren
G
G
The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada. gkoren@sickkids.ca
Hutson
J
J
Gareri
J
J
D000293:Adolescent; D000328:Adult; D019973:Alcohol-Related Disorders / Q000175:diagnosis*; D019969:Amphetamine-Related Disorders / Q000175:diagnosis; D015415:Biomarkers / Q000032:analysis; D002186:Cannabinoids / Q000009:adverse effects; D002669:Child Welfare; D002675:Child, Preschool; D019970:Cocaine-Related Disorders / Q000175:diagnosis; D004952:Esters / Q000032:analysis; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D006197:Hair / Q000737:chemistry*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008470:Meconium / Q000737:chemistry*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis*; D011297:Prenatal Exposure Delayed Effects / Q000175:diagnosis*; D015813:Substance Abuse Detection / Q000379:methods*; D019966:Substance-Related Disorders / Q000175:diagnosis*
D015415:Biomarkers; D002186:Cannabinoids; D004952:Esters; D005227:Fatty Acids